The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immune Globulin Subcutaneous-Global Market Insights and Sales Trends 2025
Synopsis
Immune globulin subcutaneous (for injection under the skin) is used to treat primary immunodeficiency
The global Immune Globulin Subcutaneous market size is expected to reach US$ 2786.8 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Immune Globulin Subcutaneous in various end use industries. The expanding demands from the Immunodeficiency, Autoimmune Disease and Acute Infection,, are propelling Immune Globulin Subcutaneous market. 2g, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4g segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immune Globulin Subcutaneous market, driven by demand from China, the second largest economy with some signs of stabilising, the Immune Globulin Subcutaneous market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune Globulin Subcutaneous, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune Globulin Subcutaneous market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune Globulin Subcutaneous market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune Globulin Subcutaneous sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune Globulin Subcutaneous covered in this report include Takeda and CSL etc.
The global Immune Globulin Subcutaneous market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Global Immune Globulin Subcutaneous market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Globulin Subcutaneous market, Segment by Type:
2g
4g
10g
Other
Global Immune Globulin Subcutaneous market, by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immune Globulin Subcutaneous manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immune Globulin Subcutaneous in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Immune globulin subcutaneous (for injection under the skin) is used to treat primary immunodeficiency
The global Immune Globulin Subcutaneous market size is expected to reach US$ 2786.8 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Immune Globulin Subcutaneous in various end use industries. The expanding demands from the Immunodeficiency, Autoimmune Disease and Acute Infection,, are propelling Immune Globulin Subcutaneous market. 2g, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4g segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immune Globulin Subcutaneous market, driven by demand from China, the second largest economy with some signs of stabilising, the Immune Globulin Subcutaneous market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immune Globulin Subcutaneous, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immune Globulin Subcutaneous market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immune Globulin Subcutaneous market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immune Globulin Subcutaneous sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immune Globulin Subcutaneous covered in this report include Takeda and CSL etc.
The global Immune Globulin Subcutaneous market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Global Immune Globulin Subcutaneous market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immune Globulin Subcutaneous market, Segment by Type:
2g
4g
10g
Other
Global Immune Globulin Subcutaneous market, by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immune Globulin Subcutaneous manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immune Globulin Subcutaneous in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Immune Globulin Subcutaneous Market Overview
1.1 Immune Globulin Subcutaneous Product Overview
1.2 Immune Globulin Subcutaneous Market Segment by Type
1.2.1 2g
1.2.2 4g
1.2.3 10g
1.2.4 Other
1.3 Global Immune Globulin Subcutaneous Market Size by Type
1.3.1 Global Immune Globulin Subcutaneous Market Size Overview by Type (2018-2029)
1.3.2 Global Immune Globulin Subcutaneous Historic Market Size Review by Type (2018-2023)
1.3.3 Global Immune Globulin Subcutaneous Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immune Globulin Subcutaneous Sales Breakdown by Type (2018-2023)
1.4.2 Europe Immune Globulin Subcutaneous Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Immune Globulin Subcutaneous Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Immune Globulin Subcutaneous Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Immune Globulin Subcutaneous Sales Breakdown by Type (2018-2023)
2 Global Immune Globulin Subcutaneous Market Competition by Company
2.1 Global Top Players by Immune Globulin Subcutaneous Sales (2018-2023)
2.2 Global Top Players by Immune Globulin Subcutaneous Revenue (2018-2023)
2.3 Global Top Players by Immune Globulin Subcutaneous Price (2018-2023)
2.4 Global Top Manufacturers Immune Globulin Subcutaneous Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immune Globulin Subcutaneous Market Competitive Situation and Trends
2.5.1 Immune Globulin Subcutaneous Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Immune Globulin Subcutaneous Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Globulin Subcutaneous as of 2022)
2.7 Date of Key Manufacturers Enter into Immune Globulin Subcutaneous Market
2.8 Key Manufacturers Immune Globulin Subcutaneous Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immune Globulin Subcutaneous Status and Outlook by Region
3.1 Global Immune Globulin Subcutaneous Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Immune Globulin Subcutaneous Historic Market Size by Region
3.2.1 Global Immune Globulin Subcutaneous Sales in Volume by Region (2018-2023)
3.2.2 Global Immune Globulin Subcutaneous Sales in Value by Region (2018-2023)
3.2.3 Global Immune Globulin Subcutaneous Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Immune Globulin Subcutaneous Forecasted Market Size by Region
3.3.1 Global Immune Globulin Subcutaneous Sales in Volume by Region (2024-2029)
3.3.2 Global Immune Globulin Subcutaneous Sales in Value by Region (2024-2029)
3.3.3 Global Immune Globulin Subcutaneous Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Immune Globulin Subcutaneous by Application
4.1 Immune Globulin Subcutaneous Market Segment by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Immune Globulin Subcutaneous Market Size by Application
4.2.1 Global Immune Globulin Subcutaneous Market Size Overview by Application (2018-2029)
4.2.2 Global Immune Globulin Subcutaneous Historic Market Size Review by Application (2018-2023)
4.2.3 Global Immune Globulin Subcutaneous Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immune Globulin Subcutaneous Sales Breakdown by Application (2018-2023)
4.3.2 Europe Immune Globulin Subcutaneous Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Immune Globulin Subcutaneous Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Immune Globulin Subcutaneous Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Immune Globulin Subcutaneous Sales Breakdown by Application (2018-2023)
5 North America Immune Globulin Subcutaneous by Country
5.1 North America Immune Globulin Subcutaneous Historic Market Size by Country
5.1.1 North America Immune Globulin Subcutaneous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Immune Globulin Subcutaneous Sales in Volume by Country (2018-2023)
5.1.3 North America Immune Globulin Subcutaneous Sales in Value by Country (2018-2023)
5.2 North America Immune Globulin Subcutaneous Forecasted Market Size by Country
5.2.1 North America Immune Globulin Subcutaneous Sales in Volume by Country (2024-2029)
5.2.2 North America Immune Globulin Subcutaneous Sales in Value by Country (2024-2029)
6 Europe Immune Globulin Subcutaneous by Country
6.1 Europe Immune Globulin Subcutaneous Historic Market Size by Country
6.1.1 Europe Immune Globulin Subcutaneous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Immune Globulin Subcutaneous Sales in Volume by Country (2018-2023)
6.1.3 Europe Immune Globulin Subcutaneous Sales in Value by Country (2018-2023)
6.2 Europe Immune Globulin Subcutaneous Forecasted Market Size by Country
6.2.1 Europe Immune Globulin Subcutaneous Sales in Volume by Country (2024-2029)
6.2.2 Europe Immune Globulin Subcutaneous Sales in Value by Country (2024-2029)
7 Asia-Pacific Immune Globulin Subcutaneous by Region
7.1 Asia-Pacific Immune Globulin Subcutaneous Historic Market Size by Region
7.1.1 Asia-Pacific Immune Globulin Subcutaneous Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Immune Globulin Subcutaneous Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Immune Globulin Subcutaneous Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Immune Globulin Subcutaneous Forecasted Market Size by Region
7.2.1 Asia-Pacific Immune Globulin Subcutaneous Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Immune Globulin Subcutaneous Sales in Value by Region (2024-2029)
8 Latin America Immune Globulin Subcutaneous by Country
8.1 Latin America Immune Globulin Subcutaneous Historic Market Size by Country
8.1.1 Latin America Immune Globulin Subcutaneous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Immune Globulin Subcutaneous Sales in Volume by Country (2018-2023)
8.1.3 Latin America Immune Globulin Subcutaneous Sales in Value by Country (2018-2023)
8.2 Latin America Immune Globulin Subcutaneous Forecasted Market Size by Country
8.2.1 Latin America Immune Globulin Subcutaneous Sales in Volume by Country (2024-2029)
8.2.2 Latin America Immune Globulin Subcutaneous Sales in Value by Country (2024-2029)
9 Middle East and Africa Immune Globulin Subcutaneous by Country
9.1 Middle East and Africa Immune Globulin Subcutaneous Historic Market Size by Country
9.1.1 Middle East and Africa Immune Globulin Subcutaneous Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Immune Globulin Subcutaneous Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Immune Globulin Subcutaneous Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Immune Globulin Subcutaneous Forecasted Market Size by Country
9.2.1 Middle East and Africa Immune Globulin Subcutaneous Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Immune Globulin Subcutaneous Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Immune Globulin Subcutaneous Products Offered
10.1.5 Takeda Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Immune Globulin Subcutaneous Products Offered
10.2.5 CSL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immune Globulin Subcutaneous Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immune Globulin Subcutaneous Industrial Chain Analysis
11.4 Immune Globulin Subcutaneous Market Dynamics
11.4.1 Immune Globulin Subcutaneous Industry Trends
11.4.2 Immune Globulin Subcutaneous Market Drivers
11.4.3 Immune Globulin Subcutaneous Market Challenges
11.4.4 Immune Globulin Subcutaneous Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immune Globulin Subcutaneous Distributors
12.3 Immune Globulin Subcutaneous Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
